Subvalvular aortic stenosis

Aortic Stenosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Aortic Stenosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Cardiac Stress Test
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Aortic Valve Area
Aortic Valve Area Calculation
Treatment
General Approach
Medical Therapy
Surgery
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty
Transcatheter Aortic Valve Replacement (TAVR) TAVR vs SAVR Critical Pathway Patient Selection Imaging Evaluation Valve Types TAVR Procedure Post TAVR management AHA/ACC Guideline Recommendations
Follow Up
Prevention
Precautions and Prophylaxis
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subvalvular aortic stenosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subvalvular aortic stenosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subvalvular aortic stenosis
CDC on Subvalvular aortic stenosis
Subvalvular aortic stenosis in the news
Blogs on Subvalvular aortic stenosis
Directions to Hospitals Treating Subvalvular aortic stenosis
Risk calculators and risk factors for Subvalvular aortic stenosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Aortic insufficiency is more common in this form of aortic stenosis and occurs in 50 to 75% of patients.

Epidemiology and Demographics

Aortic subvalvular stenosis is the second most common form of congenital left ventricular outflow tract obtruction and occurs in 8-30% of all forms of left ventricular outflow tract obstruction. The level of obstruction is located just beneath the aortic valve. HOCM (a.k.a. idiopathic hypertrophic subaortic stenosis or IHSS) is not present at birth and is not considered a congenital lesion.

Pathophysiology

There are several varieties of congenital aortic subvalvular stenosis (or subaortic stenosis):

1. Membranous: A fixed localized membrane 0.5 to 2 cm below the level of the aortic valve and attached to the septum and the base of the anterior mitral leaflet.
2. Fibromuscular:
   • More commonly there is a fibromuscular membrane or tunnel with a significant muscular component which can sometimes be hard to distinguish from IHSS. This is a more severe form and is often associated with a small aortic root.
   • Associated aortic insufficiency (AI) is often present due to the high speed jet of blood through the aortic cusps resulting in fibrosis and retraction.
3. Congenital anomalies of the mitral valve:
   • Attachment to ventricular septum of accessory chordae from anterior mitral leaflet
   • Redundant AV valve tissue causing subaortic obstruction.
4. Aneurysm of the membranous ventricular septum

Natural History

The symptoms are similar to that of valvular aortic stenosis but begin earlier in infancy or early adulthood.

Diagnosis

Symptoms

The symptoms are similar to that of valvular aortic stenosis but begin earlier in infancy or early adulthood.

Echocardiography

• High doppler gradient and normal AV.

• It may require a repeat TTE or TEE

{{#ev:youtube|YKtIXfJl3Io}}

{{#ev:youtube|s9d7fTC63KU}}

Treatment

The membrane can be resected as shown in the videos below:

{{#ev:youtube|uhW2-03jRr8}}

{{#ev:youtube|wHYVU8o0phQ}}

{{#ev:youtube|nepirb-6hqw&feature=endscreen&NR=1}}

ACC / AHA Guidelines- Recommendations for Key Issues to Evaluate and Follow-Up(DO NOT EDIT)

Class I

1. Lifelong cardiology follow-up, including evaluation by and/or consultation with a cardiologist with expertise in ACHD, is recommended for all patients with SubAS, repaired or not. (Level of Evidence: C)

2. The unoperated asymptomatic adult with stable LVOT obstruction due to SubAS and a mean gradient less than 30 mm Hg without LV hypertrophy or significant AR should be monitored at yearly intervals for increasing obstruction, the development or progression of AR, and the evaluation of systolic and diastolic LV function. (Level of Evidence: B)

Class IIa

1. Stress testing to determine exercise capability, symptoms, ECG changes or arrhythmias, or increase in LVOT gradient is reasonable in the presence of otherwise equivocal indications for intervention. (Level of Evidence: C)